Midas Pharma GmbH
Booth number: 4217-19
www.mida-pharma.com
About us
One Partner - many Opportunities. Midas Pharma is a mid-sized pharmaceutical company, founded 1988 and based in Ingelheim, Germany. Midas offers products, services and expertise along the entire pharmaceutical value chain - from Starting Materials and Active Pharmaceutical Ingredients to the development of market-ready Finished Products and Medical Devices and being marketing authorization holder for medicaments. Since over three decades the family-owned company has successfully contributed to the Pharma sector and has step by step expanded its competencies. With more than 300 employees and 10 locations in all major pharmaceutical markets worldwide Midas Pharma has excellent local know-how, local contacts and well-established networks in different pharmaceutical sectors.
Visit Midas Pharma at BIO International and www.midas-pharma.com
Address
Rheinstr. 49
55218 Ingelheim
Germany
Phone: +49 6132 990-0
Contact person:
Dr. Matthias Bauch
Global Vice President Biotechnology & Devices
E-mail: matthias.bauch@midas-pharma.com
Phone: +49 174 3104327
Products & Services
Accelerate your development of Biologics and Drug Device Combinations and benefit from the experience and comprehensive pharmaceutical support to safeguard your project executions – from pre-clinic to commercial phase.Benefit from our experience and our wide-ranging portfolio, from cell-line development, CDMO, QM, RA, PV, QP, MA holder and supply chain management service, to complete your projects.
Resilience your supply chains with our broad portfolio of biopharmaceutical ingredients and drug substances from R&D to commercial supply, as natural & unnatural Amino-acids, building blocks for Nucleic Acids (Nucleotides, Cap-analogues and Phosphoramidites) as well as Linkers & Payloads for drug conjugates. Ask us also about our customized solutions.
Multiply your licensing opportunities for innovative developments.
Biotechnology
Gx Inbeneo®
The pre-pressurized cartridge-based design allows for various drug formulations in volumes of up to 3 ml and high viscosities.
A modular platform concept facilitates a quick customization for a fast time-to-market.
